Literature DB >> 23269674

The methyltransferase NSD3 has chromatin-binding motifs, PHD5-C5HCH, that are distinct from other NSD (nuclear receptor SET domain) family members in their histone H3 recognition.

Chao He1, Fudong Li, Jiahai Zhang, Jihui Wu, Yunyu Shi.   

Abstract

The NSD (nuclear receptor SET domain-containing) family members, consisting of NSD1, NSD2 (MMSET/WHSC1), and NSD3 (WHSC1L1), are SET domain-containing methyltransferases and aberrant expression of each member has been implicated in multiple diseases. They have specific mono- and dimethylase activities for H3K36, whereas play nonredundant roles during development. Aside from the well characterized catalytic SET domain, NSD proteins have multiple potential chromatin-binding motifs that are clinically relevant, including the fifth plant homeodomain (PHD5) and the adjacent Cys-His-rich domain (C5HCH) located at the C terminus. Herein, we report the crystal structures of the PHD5-C5HCH module of NSD3, in the free state and in complex with H3(1-7) (H3 residues 1-7), H3(1-15) (H3 residues 1-15), and H3(1-15)K9me3 (H3 residues 1-15 with trimethylation on K9) peptides. These structures reveal that the PHD5 and C5HCH domains fold into a novel integrated PHD-PHD-like structural module with H3 peptide bound only on the surface of PHD5 and provide the molecular basis for the recognition of unmodified H3K4 and trimethylated H3K9 by NSD3 PHD5. Structural studies and binding assays show that differences exist in histone binding specificity of the PHD5 domain between three members of the NSD family. For NSD2, the PHD5-C5HCH:H3 N terminus interaction is largely conserved, although with a stronger preference for unmethylated H3K9 (H3K9me0) than trimethylated H3K9 (H3K9me3), and NSD1 PHD5-C5HCH does not bind to H3 peptides. Our results shed light on how NSD proteins that mediate H3K36 methylation are localized to specific genomic sites and provide implications for the mechanism of functional diversity of NSD proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23269674      PMCID: PMC3576074          DOI: 10.1074/jbc.M112.426148

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15).

Authors:  Roberto Rosati; Roberta La Starza; Angelo Veronese; Ana Aventin; Christine Schwienbacher; Teresa Vallespi; Massimo Negrini; Massimo F Martelli; Cristina Mecucci
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

2.  Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.

Authors:  Weiqun Shen; Chao Xu; Wei Huang; Jiahai Zhang; Justin E Carlson; Xiaoming Tu; Jihui Wu; Yunyu Shi
Journal:  Biochemistry       Date:  2007-02-03       Impact factor: 3.162

3.  Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin.

Authors:  Sebastian Eustermann; Ji-Chun Yang; Martin J Law; Rachel Amos; Lynda M Chapman; Clare Jelinska; David Garrick; David Clynes; Richard J Gibbons; Daniela Rhodes; Douglas R Higgs; David Neuhaus
Journal:  Nat Struct Mol Biol       Date:  2011-06-12       Impact factor: 15.369

4.  NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines.

Authors:  P O Angrand; F Apiou; A F Stewart; B Dutrillaux; R Losson; P Chambon
Journal:  Genomics       Date:  2001-05-15       Impact factor: 5.736

5.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.

Authors:  Gang G Wang; Ling Cai; Martina P Pasillas; Mark P Kamps
Journal:  Nat Cell Biol       Date:  2007-06-24       Impact factor: 28.824

8.  Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation.

Authors:  N A Farrow; R Muhandiram; A U Singer; S M Pascal; C M Kay; G Gish; S E Shoelson; T Pawson; J D Forman-Kay; L E Kay
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

9.  In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.

Authors:  Jonathan J Keats; Tony Reiman; Christopher A Maxwell; Brian J Taylor; Loree M Larratt; Michael J Mant; Andrew R Belch; Linda M Pilarski
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

10.  The Pfam protein families database.

Authors:  Marco Punta; Penny C Coggill; Ruth Y Eberhardt; Jaina Mistry; John Tate; Chris Boursnell; Ningze Pang; Kristoffer Forslund; Goran Ceric; Jody Clements; Andreas Heger; Liisa Holm; Erik L L Sonnhammer; Sean R Eddy; Alex Bateman; Robert D Finn
Journal:  Nucleic Acids Res       Date:  2011-11-29       Impact factor: 16.971

View more
  26 in total

Review 1.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

Review 2.  An evolving understanding of nuclear receptor coregulator proteins.

Authors:  Christopher J Millard; Peter J Watson; Louise Fairall; John W R Schwabe
Journal:  J Mol Endocrinol       Date:  2013-11-07       Impact factor: 5.098

Review 3.  Partners in crime: The role of tandem modules in gene transcription.

Authors:  Rajal Sharma; Ming-Ming Zhou
Journal:  Protein Sci       Date:  2015-06-11       Impact factor: 6.725

4.  Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3.

Authors:  Brittany Turner-Ivey; Ericka L Smith; Alex C Rutkovsky; Laura S Spruill; Jamie N Mills; Stephen P Ethier
Journal:  Breast Cancer Res Treat       Date:  2017-05-08       Impact factor: 4.872

Review 5.  The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.

Authors:  Iuliia Topchu; Rajendra P Pangeni; Igor Bychkov; Sven A Miller; Evgeny Izumchenko; Jindan Yu; Erica Golemis; John Karanicolas; Yanis Boumber
Journal:  Cell Mol Life Sci       Date:  2022-05-09       Impact factor: 9.207

6.  Structural and functional insights into the human Börjeson-Forssman-Lehmann syndrome-associated protein PHF6.

Authors:  Zhonghua Liu; Fudong Li; Ke Ruan; Jiahai Zhang; Yide Mei; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

7.  NRMT2 is an N-terminal monomethylase that primes for its homologue NRMT1.

Authors:  Janusz J Petkowski; Lindsay A Bonsignore; John G Tooley; Daniel W Wilkey; Michael L Merchant; Ian G Macara; Christine E Schaner Tooley
Journal:  Biochem J       Date:  2013-12-15       Impact factor: 3.857

8.  WHSC1 links transcription elongation to HIRA-mediated histone H3.3 deposition.

Authors:  Naoyuki Sarai; Keisuke Nimura; Tomohiko Tamura; Tomohiko Kanno; Mira C Patel; Tom D Heightman; Kiyoe Ura; Keiko Ozato
Journal:  EMBO J       Date:  2013-08-06       Impact factor: 11.598

9.  Disruption of NSD1 in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation.

Authors:  Nam Bui; Justin K Huang; John Paul Shen; Ana Bojorquez-Gomez; Katherine Licon; Kyle S Sanchez; Sean N Tang; Alex N Beckett; Tina Wang; Wei Zhang; Jason F Kreisberg; Trey Ideker
Journal:  Mol Cancer Ther       Date:  2018-04-10       Impact factor: 6.261

10.  Identification of protein complexes that bind to histone H3 combinatorial modifications using super-SILAC and weighted correlation network analysis.

Authors:  Natalia Kunowska; Maxime Rotival; Lu Yu; Jyoti Choudhary; Niall Dillon
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.